These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 15078817)

  • 1. p27Kip1 modulates cell migration through the regulation of RhoA activation.
    Besson A; Gurian-West M; Schmidt A; Hall A; Roberts JM
    Genes Dev; 2004 Apr; 18(8):862-76. PubMed ID: 15078817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27Kip1 expression: role of RhoA.
    Seibold S; Schürle D; Heinloth A; Wolf G; Wagner M; Galle J
    J Am Soc Nephrol; 2004 Dec; 15(12):3026-34. PubMed ID: 15579505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
    Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
    Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
    Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
    Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ; Higgins T; Jones NC; Rozengurt E
    Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin dependent kinase inhibitor p27(Kip1) is upregulated by hypoxia via an ARNT dependent pathway.
    Wang G; Reisdorph R; Clark RE; Miskimins R; Lindahl R; Miskimins WK
    J Cell Biochem; 2003 Oct; 90(3):548-60. PubMed ID: 14523989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing roles for p21(waf1/cip1) and p27(kip1) in enterocyte differentiation, proliferation, and migration.
    Stehr W; Mercer TI; Bernal NP; Erwin CR; Warner BW
    Surgery; 2005 Aug; 138(2):187-94. PubMed ID: 16153426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.
    Boehm M; Yoshimoto T; Crook MF; Nallamshetty S; True A; Nabel GJ; Nabel EG
    EMBO J; 2002 Jul; 21(13):3390-401. PubMed ID: 12093740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of the cell-cycle inhibitors p27(Kip1) and p21(Cip1) in human atherectomy specimens: primary stenosis versus restenosis.
    Braun-Dullaeus RC; Ziegler A; Bohle RM; Bauer E; Hein S; Tillmanns H; Haberbosch W
    J Lab Clin Med; 2003 Mar; 141(3):179-89. PubMed ID: 12624599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development.
    Koh KN; Kang MJ; Frith-Terhune A; Park SK; Kim I; Lee CO; Koh GY
    J Mol Cell Cardiol; 1998 Mar; 30(3):463-74. PubMed ID: 9515024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
    Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
    Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
    Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
    Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
    Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 induction of cellular migration requires p27(KIP1).
    Li Z; Jiao X; Wang C; Ju X; Lu Y; Yuan L; Lisanti MP; Katiyar S; Pestell RG
    Cancer Res; 2006 Oct; 66(20):9986-94. PubMed ID: 17047061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation.
    Fouty BW; Grimison B; Fagan KA; Le Cras TD; Harral JW; Hoedt-Miller M; Sclafani RA; Rodman DM
    Am J Respir Cell Mol Biol; 2001 Nov; 25(5):652-8. PubMed ID: 11713109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
    Touyz RM; Yao G
    J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus.
    Mann DJ; Child ES; Swanton C; Laman H; Jones N
    EMBO J; 1999 Feb; 18(3):654-63. PubMed ID: 9927425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel protein associated with membrane-type 1 matrix metalloproteinase binds p27(kip1) and regulates RhoA activation, actin remodeling, and matrigel invasion.
    Hoshino D; Tomari T; Nagano M; Koshikawa N; Seiki M
    J Biol Chem; 2009 Oct; 284(40):27315-26. PubMed ID: 19654316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA.
    Tabu K; Ohba Y; Suzuki T; Makino Y; Kimura T; Ohnishi A; Sakai M; Watanabe T; Tanaka S; Sawa H
    Mol Cancer Res; 2007 Oct; 5(10):1099-109. PubMed ID: 17951409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.